3rd Quarter - Report
TERUMO BCT, INC. for TERUMO BCT, INC.
Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
-Access to Therapeutic Apheresis, generally. -Sickle Cell Disease issues, generally; S.1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023. -Blood collection issues, generally. -Medical device sterilization.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA HECHAVARRIA | Legislative Assistant to Senator Joni Ernst; Legislative Assistant, Legislative Aide & Legislative Correspondent to Senator Mike Johanns; Staff Assistant to Senator Judd Gregg; Staff Assistant to Senator John E. Sununu |
Medicare/Medicaid MMM
-Access to Therapeutic Apheresis, generally. -Issues related to CY 2024 Physician Fee Schedule. -Issues related to CY 2024 OPPS Proposed Rule. -Sickle Cell Disease issues, generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA HECHAVARRIA | Legislative Assistant to Senator Joni Ernst; Legislative Assistant, Legislative Aide & Legislative Correspondent to Senator Mike Johanns; Staff Assistant to Senator Judd Gregg; Staff Assistant to Senator John E. Sununu |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.